Fig. 3From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trialUndetectable Viral load in Group 2 Patients (Per-Protocol Population)Back to article page